Ricardo Rezola
Overview
Explore the profile of Ricardo Rezola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Araujo A, Abaurrea A, Azcoaga P, Lopez-Velazco J, Manzano S, Rodriguez J, et al.
J Clin Invest
. 2022 Sep;
132(19).
PMID: 36169029
No abstract available.
2.
Araujo A, Abaurrea A, Azcoaga P, Lopez-Velazco J, Manzano S, Rodriguez J, et al.
J Clin Invest
. 2022 Feb;
132(7).
PMID: 35192545
The tumor microenvironment (TME) is reprogrammed by cancer cells and participates in all stages of tumor progression. The contribution of stromal cells to the reprogramming of the TME is not...
3.
Goicoechea I, Rezola R, Arestin M, Caffarel M, Cortazar A, Manterola L, et al.
F1000Res
. 2018 Jun;
6:1606.
PMID: 29862012
: The outcome for oestrogen receptor positive (ER+) breast cancer patients has improved greatly in recent years largely due to targeted therapy. However, the presence of involved multiple synchronous lymph...
4.
Bediaga N, Beristain E, Calvo B, Viguri M, Gutierrez-Corres B, Rezola R, et al.
Springerplus
. 2016 Jun;
5:623.
PMID: 27330889
Luminal B breast tumors have aggressive clinical and biological features, and constitute the most heterogeneous molecular subtype, both clinically and molecularly. Unfortunately, the immunohistochemistry correlate of the luminal B subtype...
5.
Rodriguez-Agirretxe I, Vega S, Rezola R, Vecino E, Mendicute J, Suarez-Cortes T, et al.
Invest Ophthalmol Vis Sci
. 2013 Jun;
54(8):5227-35.
PMID: 23800769
Purpose: To investigate the effect of poly (lactic-co-glycolic acid) (PLGA) implants loaded with mitomycin C (MMC) and with different adjuvant treatments after glaucoma filtration surgery (GFS), in comparison to standard...
6.
Bernet L, Martinez Benaclocha M, Castera C, Cano Munoz R, Sevilla F, Alba J, et al.
Diagn Mol Pathol
. 2012 May;
21(2):84-92.
PMID: 22555091
Monoclonal therapies could represent baseline-personalized medicine for patients with neoplasia. One of the most successful examples is Trastuzumab, a humanized antibody against epidermal growth factor receptor 2. Human epidermal growth...
7.
Bernet L, Cano R, Martinez M, Duenas B, Matias-Guiu X, Morell L, et al.
Histopathology
. 2011 May;
58(6):863-9.
PMID: 21585425
Aims: Standardization of the sentinel node (SN) as a diagnostic tool has not yet been achieved, because the protocol for histopathological study is highly variable between centres. We compared the...
8.
Bediaga N, Acha-Sagredo A, Guerra I, Viguri A, Albaina C, Ruiz Diaz I, et al.
Breast Cancer Res
. 2010 Oct;
12(5):R77.
PMID: 20920229
Introduction: Identification of gene expression based breast cancer subtypes is considered as a critical means of prognostication. Genetic mutations along with epigenetic alterations contribute to gene expression changes occurring in...
9.
Vielba R, Bilbao J, Ispizua A, Zabalza I, Alfaro J, Rezola R, et al.
Laryngoscope
. 2003 Jan;
113(1):167-72.
PMID: 12514403
Objectives/hypothesis: Proteins p53 and cyclin D1 play a crucial role in cell cycle control. Protein p53 mutations are one of the most common genetic alterations in human cancer, and cyclin...